Ensign Peak Advisors, Inc Cytokinetics Inc Transaction History

Ensign Peak Advisors, Inc

$58.8 Billion
Q3 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 20,496 shares of CYTK stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,496

Previous 31,796 35.54%

Holding current value

$1.36 Million

Previous $1.28 Million 11.82%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$33.23 - $54.96 $375,498 - $621,048	-11,300 Reduced 35.54%	20,496 $1.13 Million
Q1 2025 May 14, 2025	SELL	$40.19 - $51.12 $10.7 Million - $13.5 Million	-265,039 Reduced 89.29%	31,796 $1.28 Million
Q4 2024 Feb 13, 2025	SELL	$46.36 - $58.62 $7.65 Million - $9.67 Million	-165,001 Reduced 35.73%	296,835 $14 Million
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $81,695 - $95,955	-1,595 Reduced 0.34%	461,836 $24.4 Million
Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $1.87 Million - $2.94 Million	39,172 Added 9.23%	463,431 $25.1 Million

Q1 2024 May 14, 2024	SELL	$63.75 - $108.06 $102,255 - $173,328	-1,604 Reduced 0.38%	424,259 $29.7 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $2.2 Million - $2.73 Million	74,694 Added 21.27%	425,863 $12.5 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $280,224 - $383,964	8,400 Added 2.45%	351,169 $12.4 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $2.12 Million - $3.04 Million	59,400 Added 20.96%	342,769 $15.7 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.76 Million - $2.49 Million	45,600 Added 19.18%	283,369 $13.7 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $2.37 Million - $3.42 Million	69,904 Added 41.64%	237,769 $9.34 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $296,210 - $458,160	9,960 Added 6.31%	167,865 $6.18 Million
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $1.4 Million - $1.89 Million	-40,650 Reduced 20.47%	157,905 $7.2 Million
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $74,160 - $142,960	-4,000 Reduced 1.97%	198,555 $7.1 Million
Q2 2021 Aug 13, 2021	BUY	$19.79 - $26.99 $732,427 - $998,899	37,010 Added 22.36%	202,555 $4.01 Million
Q1 2021 May 12, 2021	BUY	$18.57 - $25.68 $1.69 Million - $2.34 Million	91,145 Added 122.51%	165,545 $3.85 Million
Q4 2020 Feb 12, 2021	SELL	$15.26 - $28.61 $748,075 - $1.4 Million	-49,022 Reduced 39.72%	74,400 $1.55 Million
Q3 2020 Nov 12, 2020	BUY	$20.58 - $28.96 $1.01 Million - $1.42 Million	49,022 Added 65.89%	123,422 $2.67 Million
Q1 2020 May 11, 2020	BUY	$8.75 - $16.3 $74,375 - $138,550	8,500 Added 12.9%	74,400 $877,000
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $523,905 - $780,256	65,900 New	65,900 $699,000

Others Institutions Holding CYTK

# of Institutions

447

Shares Held

129M

Call Options Held

5.25M

Put Options Held

1.18M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $6.25B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Cytokinetics Inc Transaction History